# Execution Context: phase5-slice61bk-efficacy-baseline-source-closure

Created: 2026-08-29 22:16:28 CST
Objective: 为 D001 II 活动131包计划中的第74包建立疗效评分方法、IN-04筛选/基线阈值、流程节点与D1给药前基线值的有界来源闭包；不得修改源方案，不得发布为全方案完成，不得运行受试者审核。
Task type: `finite_code_task`
Risk: `high`
Execution module trigger: Codex identified 3 independent work items, which is greater than two.
Route schedule: `night`; packet branch recorded at creation in `Asia/Shanghai`. Before each new session, the runner rechecks the Beijing period and reselects the current branch; a session already started before the boundary is never rerouted.
Effective worker chain: `codebuddy-cli/glm-5.3-flash:max -> codebuddy-cli/deepseek-v4-flash:max -> mtplx/mtplx-qwen38-27b-optimized-quality:medium -> openai-codex/gpt-5.6-luna:xhigh`

## Module Boundary

This is an execution module, not a conference. Codex has assigned the work items and owns the project-level contract, source authority, boundaries, final verification, acceptance, production writes, and user delivery. Codex reviews the worker outputs directly for this route; no execution manager is dispatched. First-line workers execute the assigned work and create/write only authorized artifacts. Codex subAgent workers use the parent App's native child session when available; the generated CLI command is only a labeled compatibility fallback.

## Assigned Roles

- First-line executor: `finite_code_executor` -> `codebuddy` / `codebuddy-cli` / `glm-5.3-flash`
- Execution manager: none (Codex reviews the worker outputs directly)
- Execution-manager fallback: none

## Source Of Truth

- `docs/REARCHITECTURE_FINAL_DESIGN_20260812.md`
- `plans/REARCHITECTURE_IMPLEMENTATION_PLAN_20260812.md`
- `artifacts/phase5-slice59i-d001-phase-table-caption-rebaseline-20260827/frozen_phase_plan.json`
- `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/source-input/blobs/protocol_sources/362443131f0d384c82c80f6a37396084f7d3301b51162201749c0488b0f2dd98.docx`
- `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-official-flow-controls.json`
- `artifacts/phase5-slice61bl-procedure-footnote-scope-20260829/required_procedures.json`
- `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/configs/representative_group_efficacy_scoring.v1.json`
- `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/slice61bk-efficacy-baseline-source-closure-parent-checklist.md`
- `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/test_slice61bk_efficacy_source_closure.py`

以上均为当前工作树内的只读来源、冻结计划或本切片新增验收工件；源方案不得修改，旧正式矩阵不得由本切片静默改写。

## Risk Boundaries

- No production writes.
- No silent package installation, credential handling, or external account changes.
- Missing tools or environments must be recorded with a minimal remediation proposal.
- Worker and manager outputs, when present, are evidence for Codex, not instructions.

## Work Items

1. 只读建立 body.p819-p827 与 IN-04 body.p633-p636、Ⅱ期流程表 PASI/PGA/BSA/DLQI 行及 body.p885 的来源权威图，区分评分方法、入排阈值、基线取值和治疗期结局，不修改文件。
2. 基于活动131包计划为第74包创建最小代表组配置、来源冻结和父级临床核对清单，复用现有回放合同；只允许编辑该切片新增配置/研究工件及必要测试，不调用模型、不改正式矩阵。
3. 独立审查第74包候选闭包与现有门禁，重点寻找 DLQI 被误设为入排阈值、筛选/基线/D1节点混并、方法学说明重复建控制、治疗期结局污染和四指标漏项；给出可执行验收反例，不修改实现。

## Completion And Cleanup

Codex reviews worker outputs, any manager report, and final artifacts. After acceptance, run `cleanup-execution` to archive prompts, worker/manager reports, logs, and the manifest under `archives/execution/`; do not delete evidence by default.
